A double-blind, placebo-controlled evaluation of safety and efficacy of epicutaneously applied IDEA-033 (ketoprofen in transfersome) in comparison to oral celecoxib for the treatment of pain associated with osteoarthritis of the knee.
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2009
At a glance
- Drugs Ketoprofen (Primary) ; Celecoxib
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 24 Mar 2009 IDEA added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
- 22 Nov 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History